Little is known about genetic mechanisms that regulate the ratio of cortical excitatory and inhibitory neurons. We show that NPAS1 and NPAS3 transcription factors (TFs) are expressed in progenitor domains of the mouse basal ganglia (subpallium, MGE, and CGE). NPAS1 À/À mutants had increased proliferation, ERK signaling, and expression of Arx in the MGE and CGE. NPAS1 À/À mutants also had increased neocortical inhibition (sIPSC and mIPSC) and generated an excess of somatostatin + (SST) (MGE-derived) and vasoactive intestinal polypeptide + (VIP) (CGE-derived) neocortical interneurons, but had a normal density of parvalbumin + (PV) (MGE-derived) interneurons. In contrast, NPAS3 À/À mutants showed decreased proliferation and ERK signaling in progenitors of the ganglionic eminences and had fewer SST + and VIP + interneurons. NPAS1 repressed activity of an Arx enhancer, and Arx overexpression resulted in increased proliferation of CGE progenitors. These results provide insights into genetic regulation of cortical interneuron numbers and cortical inhibitory tone.
SUMMARY
Little is known about genetic mechanisms that regulate the ratio of cortical excitatory and inhibitory neurons. We show that NPAS1 and NPAS3 transcription factors (TFs) are expressed in progenitor domains of the mouse basal ganglia (subpallium, MGE, and CGE). NPAS1 À/À mutants had increased proliferation, ERK signaling, and expression of Arx in the MGE and CGE. NPAS1 À/À mutants also had increased neocortical inhibition (sIPSC and mIPSC) and generated an excess of somatostatin + (SST) (MGE-derived) and vasoactive intestinal polypeptide + (VIP) (CGE-derived) neocortical interneurons, but had a normal density of parvalbumin + (PV) (MGE-derived) interneurons. In contrast, NPAS3 À/À mutants showed decreased proliferation and ERK signaling in progenitors of the ganglionic eminences and had fewer SST + and VIP + interneurons. NPAS1 repressed activity of an Arx enhancer, and Arx overexpression resulted in increased proliferation of CGE progenitors. These results provide insights into genetic regulation of cortical interneuron numbers and cortical inhibitory tone.
INTRODUCTION
While rapid progress has been made in understanding the regulation of neural regional and cell fate specification, much less is known about genetic mechanisms underlying brain size and how the correct ratios of excitatory and inhibitory neurons within local circuits are generated. Understanding these mechanisms is essential for elucidating important facets of brain development that underlie neurodevelopmental disorders that may have an imbalance of cortical excitation/inhibition (E/I) (e.g., epilepsy, autism spectrum disorders [ASDs] , and schizophrenia) (Lewis et al., 2012; Marín, 2012; Rubenstein and Merzenich, 2003; Yizhar et al., 2011) , and to understanding why many autistic children have macrocephaly that includes a large cerebral cortex (Courchesne et al., 2007; Hazlett et al., 2011) . While unifying genetic mechanisms which control cortex size and E/I balance have not yet been elucidated, progress has been made in understanding each of these processes individually.
Genetic causes of human neonatal macrocephaly are present in individuals with mutations in genes regulating growth factor signaling, particularly in pathways that engage the function of AKT and PTEN (Poduri et al., 2012; Riviè re et al., 2012; Striano and Zara, 2012; Zhou and Parada, 2012) , and RAS and MAPK (Gripp et al., 2013) . For instance, patients who are heterozygotes for loss-of-function PTEN mutations have macrocephaly and are at increased risk for autism (Zhou and Parada, 2012) .
Likewise, progress has been made in understanding the mechanisms that control the generation of cortical excitatory and inhibitory neurons (Gelman et al., 2012; Kwan et al., 2012; Marín, 2013) and the mechanisms that coordinate their relative activities to create the proper E/I balance (Le Magueresse and Monyer, 2013) . In this regard, there is particular interest in the mechanisms that control the development of cortical inhibitory neurons (GABAergic interneurons). In rodents, most cortical inhibitory neurons are generated during embryogenesis in subpallial structures called the caudal and medial ganglionic eminences (CGEs and MGEs) (Rudy et al., 2011) .
The specification, migration, and differentiation of cortical interneurons are controlled by cascades of transcription factors (TFs). Some TFs regulate the development of either CGE-or MGE-derived neurons. For instance, Lhx6, Nkx2-1, Olig1, and Sox6 regulate for the specification and differentiation of MGEderived interneurons (Azim et al., 2009; Batista-Brito et al., 2009; Liodis et al., 2007; Silbereis et al., 2014; Sussel et al., 1999; Zhao et al., 2008) . Other TFs, such as the Arx and Dlx genes, control development of both CGE-and MGE-derived interneurons (Cobos et al., 2005; Colasante et al., 2008; Marsh et al., 2009 ).
Herein, we present evidence that the mouse NPAS basic helixloop-helix (bHLH)-PAS TF genes (Erbel-Sieler et al., 2004; Pieper et al., 2005; Zhou et al., 1997) are regulators of cortex size and E/I balance. NPAS1 and NPAS3 are expressed in telencephalic progenitor domains of the cortex, and the CGE and MGE, and later in immature and mature cortical interneurons (Batista-Brito et al., 2008; Erbel-Sieler et al., 2004; Zhao et al., 2008) . Vertebrate NPAS function in embryonic neural progenitors may be related to the function of Trachealess, the NPAS Drosophila homolog. Trachealess modulates fibroblast growth factor (FGF) signaling by transcriptional regulation of the FGF receptor (Ohshiro and Saigo, 1997) . In the adult mouse hippocampus, NPAS3 regulates expression of FGFR1 to control proliferation of hippocampal granule neurons (Pieper et al., 2005) . Here, we have found that NPAS1 negatively regulates proliferation and MAPK signaling in CGE and MGE progenitors, not by regulating FGF receptor expression but through an unexpected mechanism, repression of Arx expression. As a result, NPAS1 À/À mutants generated excessive cortical interneurons prenatally, which persisted into adulthood. NPAS1 À/À mutants also had increased neocortical inhibition (sIPSC and mIPSC) and generated an excess of SST + (MGE-derived) and VIP + (CGE-derived) neocortical interneurons, but had normal numbers of PV + (MGE-derived) interneurons. In contrast, NPAS3 À/À mutants had a complementary phenotype, with reduced proliferation and MAPK signaling in progenitors of the ganglionic eminences, and the postnatal cortex had fewer SST + and VIP + interneurons. We propose that our analysis of NPAS1 and NPAS3 functions in mice provides mechanistic insights into human neuropsychiatric disorders, as NPAS3 dysfunction is implicated in schizophrenia (Kamnasaran et al., 2003; Macintyre et al., 2010) . Furthermore, we have identified sporadic nonsynonymous mutations in NPAS1 and NPAS3 in autistic individuals.
RESULTS

NPAS1 and NPAS3 Expression during Interneuron Development
The subpallium generates neocortical interneurons (Flandin et al., 2011; Marín, 2012; Rudy et al., 2011) . We examined NPAS1 and NPAS3 RNA expression by in situ hybridization (ISH) at E13.5, E15.5, and P5 ( Figure 1 ) and assessed NPAS1 and NPAS3 expression by immunofluorescence at P0, P5, P15, and P30 ( Figure 1 , and see Figures S1 and S2 and Tables S1 and S2 available online). At E13.5, both had pallial and subpallial ventricular zone (VZ) expression. NPAS1 showed notable expression in the VZ and subventricular zone (SVZ) of the dorsal and ventral MGE, and CGE. By E15.5, NPAS3 was expressed in the MGE mantle zone; NPAS1 expression was prominent in the pallial and subpallial SVZ.
Previous studies have described coexpression of NPAS1 or NPAS3 with cortical interneurons using GABA, GAD-67, or calretinin antibodies in the adult mouse brain (Erbel-Sieler et al., 2004) . We have extended coexpression analysis of NPAS1 or NPAS3 with various interneuron markers during cortical interneuron development and in the adult (Figures 1, S1 , and S2; Tables S1  and S2 ). At P0, NPAS1 was expressed in neocortical interneurons; $100% of NPAS1 + cells express GAD67-GFP; $30%
had MGE-like properties (Lhx6-GFP + ) ( Figures 1D, 1F , S1A, and S1B). By P5, NPAS1 and NPAS3 were expressed in rostrocaudal gradients in neocortical interneurons; we are unaware of other TFs with this property. Virtually all neocortical NPAS1 + cells (99% ± 0.29%) and the majority of NPAS3 + cells (67% ± 2.94%) expressed GAD67-GFP at P5 ( Figures S1C and S1D ). By P15, NPAS1 and NPAS3 were expressed by a majority of reelin + (NPAS1, 68% ± 2.78%; NPAS3, 79% ± 4.79%) and SST + (NPAS1, 65% ± 1.95%; NPAS3, 75% ± 0.44%) interneurons. Both NPAS1 and NPAS3 were expressed in a small proportion of PV + cells (NPAS1, 6% ± 0.85%) (NPAS3, 13% ± 1.29%) (Figures S1E , S1F, S1H-S1J, and S1L). At P30, NPAS1
+ cells coexpressed reelin, SST, calretinin (CR), or neuropeptide Y (NPY) but rarely coexpressed PV (reelin, 42% ± 1.94%; SST, 36% ± 3.72%; CR, 28% ± 2.89%; NPY, 12% ± 0.70%; PV, 5% ± 1.24%). On the other hand, NPAS3 + was expressed in a large fraction of all interneuron subtypes assayed, including PV (reelin, 74% ± 2.31%; SST, 75% ± 3.52%; CR, 51% ± 1.23%; PV, 43% ± 1.40%) ; data not shown).
Increased Numbers of Neocortical Interneurons in
We studied the effect of an NPAS1 null allele (NPAS1 Sieler et al., 2004) on neocortical interneuron development using a GAD67-GFP allele to label all of the interneurons (Tamamaki et al., 2003) . By E15.5 there was an increased density of GFP + interneurons through the intermediate zone and then throughout the cortical wall at E17.5 and P0 (26%-41%; E15.5, 26% ± 4.67%, p = 0.00099; E17.5, 35% ± 2.08%, p = 9.08E-8; P0, 41% ± 4.46%, p = 2.48E-6) ( Figures 2A-2C and 2E-2G). Even though there was $2-fold increased interneuron cell death at P7 (activated caspase-3, Figures S3A and S3B ), P30 mice maintained $15% (15% ± 5.43%, p = 0.044) more interneurons ( Figures 2D and 2H) . , 11.18 ± 1.26 Hz; p = 0.042). However, the amplitudes and kinetics of inhibitory events were not significantly changed (Figures 4A and 4B) . To further characterize the increase in GABA-mediated synaptic inhibition, tetrodotoxin (TTX) was added to the ACSF to isolate miniature IPSCs (mIPSCs). Similar to spontaneous events, an increase in mIPSC frequencies was observed in NPAS1 À/À mice (WT, 6.2 ± 1.24 Hz; NPAS1 À/À , 8.74 ± 1.02 Hz; p = 0.036); amplitudes and kinetics of mIPSCs were not significantly changed ( Figure 4C ).
Next, we evaluated the ratio of interneuron numbers to total neuron numbers by quantifying the percentage of NeuN + cells (total neurons) that express GAD67-GFP in each layer of P21 somatosensory cortex ( Figures S4B and S4C) . At P21, all NeuN + cells were GAD67-GFP + in layer I somatosensory cortex.
NPAS1
À/À mutant mice displayed a 19% increase (19% ± 5.94%, p = 0.025) in GAD67-GFP + interneurons within layer I ( Figure S4C ). In layer II/III, the percentage of NeuN + cells that express GAD67-GFP was increased by 18% in NPAS1 À/À mu-
, 32% ± 0.96%, p = 0.0024) (Figures 4D-4I ). We also estimated the excitatory to inhibitory cell ratio (E/I) in each cortical layer at P21. The E/I ratio, determined as the ratio of NeuN + and GAD67 À cells to GAD67 + cells, was decreased by 23% in layer II/III of the
, 2.12 ± 0.091, p = 0.0040) ( Figure S4D ). No significant change in the E/I cell ratio was found in deep cortical layers (IV, V, or VI) ( Figure S4D ). These findings were supported by stereological quantification of NeuN + and GAD67 + cells within the cerebral cortex. The NPAS1 À/À mutant cerebral cortex ex- 
-/-and NPAS3 -/-Had Opposite Effects on Cortical Interneuron Numbers NPAS3 À/À mice display reduced proliferation and size of the adult hippocampal dentate gyrus (Pieper et al., 2005 In addition, we observed probable NPAS1
3F-3H, and 3J
, and NPAS1/3 À/À mutant basal ganglia phenotypes (n = 1), which include subtle cholinergic defects (NPAS1 and NPAS3 are expressed in the pallidum) ( Figure 1 and data not shown) (Flandin et al., 2010; Nó bregaPereira et al., 2010 5R , and 5W).
BrdU labeling analysis of E13.5 MGE and CGE progenitors, utilized to detect cells in S phase, supported the PH3 results. One hour BrdU pulse labeling showed increased proliferation in the SVZ of the NPAS1 À/À mutant MGE (total number, 31% ± 1.26%, p = 0.0007; density, 48% ± 2.15%, p = 0.0004) and CGE (total number, 19% ± 3.31%, p = 0.039; density, 34% ± 5.24%, p = 0.022), while NPAS3 À/À mutant mice exhibited decreased proliferation in the MGE SVZ (total number, 26% ± 2.05%, p = 0.0018; density, 21% ± 3.08%, p = 0.023) ( Figures  S5A-S5E ). In addition, examination of proliferation in the hippocampal dentate gyrus following intraperitoneal injection of BrdU once daily for 12 days revealed a 31% increase (31% ± 7.89%, p = 0.003) in BrdU + cells in 5-to 10-week-old NPAS1 À/À mice ( Figures S5F and S5G ).
The NPAS Drosophila homolog Trachealess regulates FGF signaling (Ohshiro and Saigo, 1997) ; thus we examined activation of the MAP kinase pathway by measuring the level of phospho-ERK immunofluorescence. NPAS1 mutants had a 1.3-fold increase (E13.5 CGE, 1.32 ± 0.043, p = 0.0016; E15.5 MGE, 1.35 ± 0.063, p = 0.00017) in phospho-ERK expression in the E13.5 CGE and E15.5 MGE, whereas NPAS3 mutants exhibited a 1.3-fold decrease (1.26 ± 0.060, p = 0.0079) in phospho-ERK expression in the E13.5 CGE and a 1.2-fold decrease (1.17 ± 0.024, p = 0.023) in the E13.5 MGE ( Figures 5C, 5D , 5G, 5H, 5J, 5L, 5O, 5P, 5S, 5T, 5V, and 5X).
NPAS1
-/-Ganglionic Eminences Displayed Increased Arx Expression which Mediated an Increase in Subpallial MAP Kinase Activity and Proliferation We focused on identifying molecular mechanisms underlying the increased proliferation and phospho-ERK expression in the MGE and CGE of NPAS1 mutants by ISH screening of the MGE and CGE for expression of genes that are implicated in these processes (Arx, Cyclin D1, Cyclin D2, Dlx1, ErbB4, FGFR1, FGFR3, Lhx2, Lhx6, NPAS3, Olig1, Sp8, and Sprouty2) (Figures 6 and S5 ; data not shown). While we did not find robust changes for most of these, including FGF-signaling components, there were some interesting changes in Arx and Sp8 expression. In accordance with the increase in CGE proliferation, there was a subtle increase in Sp8 + (LGE/CGE marker) migrating interneurons at E13.5 ( Figure 6B ) (Ma et al., 2012) . We also observed a clear increase of Arx TF RNA at E13.5 and E15.5 in regions of the MGE and CGE where NPAS1 is normally expressed ( Figures  6A and 6C) . Arx function is necessary for proper interneuron migration and maturation (Colombo et al., 2007; Kitamura et progenitor proliferation (Friocourt et al., 2008; Kitamura et al., 2002) . To test whether NPAS1 and its cofactor, ARNT, can directly repress Arx expression through a known Arx subpallial enhancer element (Colasante et al., 2008; Visel et al., 2013) , we performed luciferase assays in CGE primary cultures (Flandin et al., 2011) . We found that this enhancer had two putative NPAS1/ARNT sites, designated A and B ( Figure S7D ) (Hogenesch et al., 1997) . Consistent with the aforementioned phenotype, NPAS1/ ARNT induced an $2-fold repression of the Arx enhancer (0.58 ± 0.035, p = 6.69E-5). Mutation of the Arx enhancer at site A, but not site B, resulted in a rescue of the repression induced by NPAS1/ARNT (p = 0.034) (Figures 7C and 7D) .
Next, to investigate whether the increase in Arx expression ( Figures 6A and 6C) could alter subpallial development, we used ultrasound to guide injection into the E13.5 CGE of a lentivirus encoding either Arx and GFP, or GFP alone. At E15.5, we compared the number of PH3 + /GFP + cells and observed that the Arx-encoding virus increased PH3 + /GFP + cells by $2-fold (2.18 ± 0.039, p = 0.042) ( Figures 7A, 7B , and S7A). We also assessed the level of phospho-ERK expression in GFP + regions of the CGE ventricular zone and found that Arx overexpression increased phospho-ERK expression by 1.4-fold (1.39 ± 0.12, p = 0.046) ( Figures S7B and S7C ). These findings provide evidence that NPAS1 repression of Arx can regulate CGE proliferation and MAP kinase activity.
Nonsynonymous Mutations in NPAS1 and NPAS3 Are Found in Humans with ASD NPAS3 mutations are observed in patients with schizophrenia (Kamnasaran et al., 2003; Macintyre et al., 2010) . Given that ASDs and schizophrenia share some genetic risk factors (M-T) NPAS3 À/À progenitors display reduced proliferation and MAP kinase activity in the E13.5 MGE (Q-T). While MAP kinase activity was decreased in the E13.5 CGE (O and P), proliferation of progenitors was unaltered in the E13.5 CGE (M and N) of NPAS3 À/À mutant mice.
(U-X) Quantification of phosphohistone H3 + (U and W) cells and phospho-ERK (V and X) levels in NPAS3 À/À mutants. Proliferation was measured in the VZ and SVZ (white boxes). Phospho-ERK levels in the CGE/MGE (white box) were normalized by comparison with cortical levels (yellow box). n = 3 animals per genotype for (U)-(X). Abbreviations are as follows: CGE, caudal ganglionic eminence; Cx, cortex; MGE, medial ganglionic eminence; SVZ, subventricular zone; VZ, ventricular zone. *p < 0.05. **p < 0.01. ***p < 0. Figure S5 . (Murdoch and State, 2013) and, like NPAS1 mutant mice, enlarged brain size is frequent in ASD children (Butler et al., 2005; Hazlett et al., 2011) , we screened 947 ASD probands for mutations in NPAS1 and NPAS3 exons, introns, and 5 0 and 3 0 untranslated regions, and found ten nonsynonymous variants in NPAS1 and seven in NPAS3 (see the Supplemental Information). We assayed 13 of those in 190 control subjects (unscreened for autism) and found that five of seven in NPAS1 and all six in NPAS3 were absent in the controls. Although the data lack sta- Figure S6 . tistical power and do not unambiguously implicate these variants in genetic susceptibility to ASD, these results support the possibility that NPAS1 and NPAS3 mutations are related to ASD risk.
Scale bar, (A)-(H) and (M)-(T), 250 mm. See also
DISCUSSION
NPAS1
À/À mice had increased numbers of neocortical interneurons, whereas NPAS3 À/À mice have fewer interneurons
00 , 3E 00 , 3F-3H, and 3J). These changes in interneuron numbers were associated with altered ERK signaling and cell proliferation within the MGE and CGE of NPAS1 À/À and NPAS3 À/À mutants (Figure 5 ). In addition, the increased numbers of neocortical interneurons in NPAS1 À/À mice resulted in enhanced synaptic inhibition onto neocortical pyramidal neurons in layer II/III of the somatosensory cortex ( Figures 4A-4C ). We focused on how NPAS1 regulates this process in the MGE and CGE and found that NPAS1 À/À mutants had increased Arx expression in these embryonic progenitor zones ( Figures 6A and 6C ). Using in utero transduction of Arx into the CGE, we showed that increased Arx expression was sufficient to increase subpallial proliferation and MAP kinase activity ( Figures 7A, 7B , S7B, and S7C). We also demonstrated that NPAS1 could directly repress a bone fide Arx subpallial enhancer ( Figures 7C, 7D , and S7D) (Colasante et al., 2008) .
Our results provide insights into mechanisms that control the number of specific subtypes of cortical inhibitory neurons, showing that homologous TF-encoding genes NPAS1 and NPAS3 have opposing functions in regulating the numbers of SST + and VIP + interneurons ( Figures 3A-3A 00 , 3E-3E 00 , 3F, and 3J). Thus, we have provided evidence for a cell-autonomous (C) Arx locus on mouse X chr, showing evolutionarily conserved domains, one of which is a subpallial enhancer (UAS3) (Colasante et al., 2008; Visel et al., 2013) that has two predicted NPAS1/ARNT sites ( Figure S6 ). mechanism that controls interneuron numbers, a process proposed to exist based on results from the MGE-transplantation assay (Southwell et al., 2012) .
NPAS1 and NPAS3 Regulate the Proliferation of Ganglionic Eminence Progenitors
Proliferation and ERK signaling in progenitor domains of the MGE and CGE were increased and decreased in NPAS1
and NPAS3 À/À mice, respectively ( Figure 5 ). Vertebrate NPAS function in embryonic neural precursors may be related to the function of Trachealess, the NPAS Drosophila homolog. Trachealess promotes FGF-signaling by increasing expression of the FGF receptor (Ohshiro and Saigo, 1997) . This program is evolutionarily conserved based on the observation that NPAS3 À/À mice have reduced FGFR1 expression in the adult hippocampus (Pieper et al., 2005) . However, NPAS3 À/À mutant mice did not show this phenotype in the prenatal telencephalon (data not shown). Also, NPAS1 À/À mutants did not exhibit decreased FGFR1 expression in the adult hippocampus (Pieper et al., 2005) , or in the prenatal telencephalon ( Figure S6C ). Thus, there is no evidence that changes in phospho-ERK levels, in the subpallium of NPAS1 À/À and NPAS3 À/À mutants ( Figures 5C,   5D , 5G, 5H, 5J, 5L, 5O, 5P, 5S, 5T, 5V, and 5X), are related to altered FGF signaling. Our study reveals insights into NPAS1 regulation of cell proliferation. Here, we have found that the increase in proliferation and MAPK signaling in NPAS1 À/À mutant CGE and MGE progenitors was associated with increased Arx expression. Previous studies of Arx mutant mice show that lack of this TF resulted in reduced cortical proliferation (Friocourt et al., 2008; Kitamura et al., 2002) . We demonstrated that increased Arx expression was sufficient to enhance subpallial proliferation and MAP kinase activity, using in utero transduction of Arx into the CGE ( Figures 7A, 7B , S7B, and S7C). Furthermore, we showed that NPAS1 could directly inhibit a bone fide Arx subpallial enhancer ( Figures 7C, 7D , and S7D) (Colasante et al., 2008) . Given that NPAS1 and NPAS3 have opposite effects on proliferation, an imbalance of either NPAS1 or NPAS3 expression and/or function could potentially be compensated by changes in the expression of the other gene. However, we did not observe changes of NPAS3 expression in the NPAS1 À/À E13.5 and P0
forebrain (data not shown).
NPAS1 and NPAS3 Modified the Production of Specific Subtypes of Cortical Interneurons
The increase in Arx and phospho-ERK expression and the increase in proliferation in the MGE and CGE of NPAS1 À/À mutants were associated with an increase in subpallially derived cortical interneurons ( Figure 2) . As a result, NPAS1 mutants had excessive SST + and VIP + interneurons, products of the MGE and CGE, respectively ( Figures 3A, 3A 0 , 3E, 3E 0 , 3F, and 3J) (Rudy et al., 2011) . In contrast, decreased phospho-ERK expression and cell proliferation in the MGE and CGE of NPAS3 À/À mutant mice resulted in reduced numbers of SST + and VIP + interneurons ( Figures 3A, 3A 00 , 3E, 3E 00 , 3F, and 3J). Both NPAS1 and NPAS3 mutants had a normal density of PV + interneurons ( Figures 3D-3D 00 and 3I). PV and SST are MGE derived (Rudy et al., 2011) . NPAS1, along with NPAS3, COUP-TFI, Dlx1, and SatB1 (Cobos et al., 2005; Denaxa et al., 2012; Lodato et al., 2011) , define a set of TFs that differentially regulate the numbers of interneurons that express PV and SST ( Figures  3D-3D 00 , 3E-3E 00 , 3I, and 3J). At least one PV + subtype, the Chandelier neuron, is generated late in gestation (Inan et al., 2012; Taniguchi et al., 2013) ; perhaps NPAS1 and NPAS3 regulation of MGE proliferation is time dependent, and thus preferentially affects early-born SST + interneurons. Based on the embryonic phenotypes of NPAS1 À/À and NPAS3 À/À mutants, we propose that NPAS1 and NPAS3 control the SST/PV ratio via their functions in MGE progenitor cells. Future studies are needed to examine the roles of NPAS1 and NPAS3 in regulating interneurons via their expression in maturing and mature interneurons ( Figure 1C ). The significance of transcriptional repression in the regulation of cortical interneuron number is becoming apparent. A recent study demonstrates that Olig1 inhibits the generation of GABAergic interneurons produced in the MGE by repression of Dlx expression through the Dlx1/2 I12b intergenic enhancer (Silbereis et al., 2014) . Likewise, NPAS1 inhibits the generation of cortical interneurons by repression of Arx expression through the subpallial Arx enhancer, which mediates CGE progenitor cell proliferation (Figure 7 ) (Colasante et al., 2008) .
NPAS1 Function in Interneuron Generation Controls Cortical Excitation/Inhibition
NPAS1
À/À mutant mice display increased numbers of GAD67-GFP + interneurons in layer I ( Figure S4C ). It is likely that an excess of GABAergic neurons in layer I would have an effect on the inhibitory tone of pyramidal cell dendrites within this layer. NPAS1 mutants also exhibit excessive SST + and VIP + interneurons. VIP + interneurons are enriched in layers II/III (Kawaguchi and Kubota, 1997; Miyoshi et al., 2010) and form synapses with pyramidal cell somata and dendrites (Kawaguchi and Kubota, 1996) and other interneurons (Acsá dy et al., 1996; Dá vid et al., 2007; Hajos et al., 1996) . Thus, with an increase in both SST + and VIP + interneurons, it is difficult to deduce the net physiological effect a priori. We found that NPAS1 mutants had enhanced cortical inhibition in layer II/III of the somatosensory cortex (Figure 4) , implying that the increase in interneurons resulted in a net increase in inhibition in superficial cortical layers. The enhanced cortical inhibition in layer II/III somatosensory cortex of NPAS1 À/À mutants suggests a decreased E/I ratio in layer II/III somatosensory cortex. This is supported by estimation of the cellular E/I ratio within this cortical region of NPAS1 À/À mutant mice ( Figure S4D ). While increased cortical inhibition is likely to reduce noise in the cortex, and it could be protective for epilepsy, it may be detrimental to cortical function by dampening cortical signals and thereby predispose to neuropsychiatric disorders.
NPAS1 and NPAS3 in Human Neuropsychiatric Disorders Our examination of NPAS1 and NPAS3 functions in mice provides mechanistic insights into human neuropsychiatric disorders. NPAS3 À/À mutant mice display behavioral and neuroanatomical deficits associated with human schizophrenia (ErbelSieler et al., 2004) , and NPAS3 mutations are observed in patients with schizophrenia (Kamnasaran et al., 2003; Macintyre et al., 2010) . Furthermore, NPAS1 mutant mice exhibit an increase in brain size ( Figures S3D-S3G ), similar to the enlargement seen in some children with ASD (Butler et al., 2005; Hazlett et al., 2011) . Notably, we have found sporadic nonsynonymous mutations in NPAS1 and NPAS3 in individuals with ASD, which suggests that NPAS1 and NPAS3 mutations may be associated with ASD risk. However, our analyses lack the statistical power to conclude that these alleles contribute to ASD. Nonetheless, these data, and the experimental analyses of the mouse mutants, strongly suggest that further genetic analyses of NPAS1 and NPAS3 are warranted in human neuropsychiatric disorders. ; NPAS3 +/À males also produced C57Bl/6J strain litters.
NPAS3
À/À mutant mice obtained from this cross were utilized for BrdU analysis of the ganglionic eminences, assessment of cortical layer-specific markers, and in the examination of interneuron markers in the P30 somatosensory cortex. However, due to increased mortality of NPAS3 À/À mutants maintained on a C57BL/6J strain background, subsequent experiments were performed with NPAS3 À/À mutant mice maintained on a CD-1 strain background. These experiments include assessment of apoptosis within the somatosensory cortex, examination of PH3 and phospho-ERK expression in the ganglionic eminences, and MRI analysis. The Lhx6-GFP BAC transgenic mouse line was obtained from the Gene Expression Nervous System Atlas Project (GENSAT) at The Rockefeller University (New York). GAD67-GFP mice were genotyped as described by Tamamaki and colleagues (Tamamaki et al., 2003) . As a note on nomenclature, experimental samples designated as NPAS1 +/+ indicate that the NPAS1 allele is unaltered; however, data from these mice are not referred to as WT because they have either the Lhx6-GFP or GAD67-GFP alleles. Results are expressed as mean ± SEM. Statistical differences between experimental groups were assessed with the Mann-Whitney U test using SigmaPlot 12.3 software (SYSTAT).
Primary Cell Culture and Luciferase Assays CGE tissue was dissected from E12.5 WT embryos and mechanically dissociated with a P1000 pipette tip. A total of 200,000 cells were seeded into tissue culture dishes precoated with poly-L-lysine 10 mg/ml, Sigma) and then laminin (5 mg/ml, Sigma), and grown in N5 media (DMEM-F-12 with glutamax, N2 supplement, 35 mg/ml bovine pituitary extract, 20 ng/ml bFGF, and 20 ng/ml EGF) as previously described for MGE cells (Flandin et al., 2011) . CGE primary cultures were transfected using Fugene 6 (Promega) with DNA expression vectors and reporters comprising four conditions: (1) empty firefly-luciferase reporter (PGL4.23) and a control DNA expression vector only expressing GFP (CMV-GFP), (2) empty PGL4.23 and CMV-NPAS1, (3) Arx enhancer (UAS3-PGL4.23) luciferase reporter and CMV-GFP, and (4) UAS3-PGL4.23 and CMV-NPAS1. All conditions also included the same amounts of CMV-ARNT (NPAS cofactor) and Renilla-luciferase (normalization control). Cell lysates were collected at 2 days posttransfection and procedures were performed according to the manufacturer's protocol (Promega, dual luciferase assay system). Enhancer activity for each condition was determined from three independent experiments, each performed in triplicate. Results were calculated as mean ± SEM and presented as fold change relative to the basal condition containing CMV-GFP and the PGL4.23 empty luciferase reporter vector. Statistical differences between experimental groups were determined with the Student's t test using SPSS 15 software (IBM). See the Supplemental Experimental Procedures for details on expression and luciferase reporter vectors.
Virus Production and In Utero Injection
HEK293T cells grown in DMEM H21 with 10% FBS were transfected with four plasmids to generate lentivirus particles, (pVSV-g, pRSVr, pMDLg-pRRE, and the lentiviral vector). Cells were transfected at $70% confluency, and media was completely replaced 4 hr after transfection, then cultured for 4 days days before harvesting. On day 4 of culture, all the media ($35 ml) was collected and filtered through a 0.45 low protein binding membrane to remove cells and large debris. The filtered media was pooled and ultracentrifuged at 100,000 3 g for 2.5 hr at 4 C. After the ultracentrifuge step, supernatant was removed, and the pellet was resuspended overnight in sterile PBS, then stored at À80 C until use. For infection, recipient pregnant females (E13.5) were anesthetized with isoflurane, their uterine horns exposed, and mounted under an ultrasound microscope (Vevo 770, VisualSonics). A beveled glass micropipette ($50 mm diameter) was front loaded with CMV-GFP or CMV-GFP-T2a-Arx lentivirus and inserted into the VZ of the CGE under real-time ultrasound guidance imaging. Approximately 1 ml of solution was injected into the VZ of the CGE. Three successfully injected animals were analyzed 2 days later (E15.5) for each experimental condition. 
